HUMORAL-FACTORS DETERMINING THE BLOOD-PRESSURE RESPONSE TO CONVERTING ENZYME-INHIBITION AND CALCIUM-CHANNEL BLOCKADE

被引：13

作者：

EVANS, RR ^{[1
]}

DAVIS, WR ^{[1
]}

WALLACE, JM ^{[1
]}

DIPETTE, DJ ^{[1
]}

HOLLAND, OB ^{[1
]}

机构：

[1] UNIV TEXAS,MED BRANCH,DEPT INTERNAL MED,RM 4156,OJSH,RT E72,GALVESTON,TX 77550

来源：

AMERICAN JOURNAL OF HYPERTENSION | 1990年 / 3卷 / 08期

关键词：

Angiotensin converting enzyme; Calcium channel blocker; Captopril; Diltiazem;

D O I：

10.1093/ajh/3.8.605

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

Renin and catecholamine levels were determined in patients with mild to moderate hypertension before and after treatment with sustained release diltiazem or captopril and were correlated with the blood pressure response to these antihypertensives. Eight weeks of treatment with either agent led to equal decreases in both systolic and diastolic blood pressure. Pretreatment plasma renin activity (PRA) and plasma norepinephrine did not predict the blood pressure response to either agent. Diltiazem significantly increased both PRA and supine norepinephrine levels. However, in the diltiazem treated patients, there was no correlation between the change in plasma norepinephrine and the change in systolic or diastolic blood pressure. In contrast, there was a negative correlation (P <.05) between the reactive rise in PRA and the decrease in systolic blood pressure. Thus, the antihypertensive response to a calcium channel blocker may be determined, in part, by the reactive response of pressor systems. © 1990 by the American Journal of Hypertension, Ltd.

引用

页码：605 / 610

页数：6

共 33 条

[1]

The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure, Arch Intern Med, 148, pp. 1023-1038, (1988)

[2]

Cody R.J., Laragh J.H., Case D.B., Atlas S.A., Renin system activity as a determinant of response to treatment in hypertension and heart failure, Hypertension, 5, pp. III-36-III-42, (1983)

[3]

Erne P., Bolli P., Bertel O., Et al., Factors influencing the hypotensive effects of calcium antagonists, Hypertension, 5, pp. II-97-II-102, (1983)

[4]

Kiowski W., Bertel O., Erne P., Et al., Hemodynamic and reflex responses to acute and chronic antihypertensive therapy with the calcium entry blocker nifedipine, Hypertension, 5, pp. I-70-I-74, (1983)

[5]

Agabiti-Rosei E., Alicandri C., Fariello R., Muiesan G., Catecholamines and hemodynamics in fixed essential hypertension, Clin Sci, 571, pp. 193s-196s, (1979)

[6]

Hussain M.N., Benedict C.R., Radioenzymatic microassay for simultaneous estimations of dopamine, norepinephrine, and epinephrine in plasma, urine, and tissues, Clin Chem, 31, pp. 1861-1864, (1985)

[7]

Sealey J.E., Laragh J.H., How to do a plasma renin assay, Topics in hypertension, pp. 244-256, (1980)

[8]

Swartz S.L., Endocrine and vascular responses in hypertensive patients to long-term treatment with diltiazem, J Cardiovasc Pharmacol, 9, pp. 391-395, (1987)

[9]

Schulte K.-L., Meyer-Sabellek W.A., Haertenberger A., Et al., Antihypertensive and metabolic effects of diltiazem and nifedipine, Hypertension, 8, pp. 859-865, (1986)

[10]

Low-dose captopril for the treatment of mild to moderate hypertension, Arch Intern Med, 144, pp. 1947-1953, (1984)

← 1 2 3 4 →